# enGene Therapeutics Inc.: Form SC 13D/A, filed Oct 18, 2024

- Company: [enGene Therapeutics Inc.](/companies/engn.md) (CIK 1980845)
- Form: SC 13D/A
- Filed: 2024-10-18
- Accepted by EDGAR: Oct 18, 2024, 16:15 ET
- Period: not reported
- Accession: 0001193125-24-239641
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1980845/000119312524239641/d889944dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1980845/000119312524239641/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1980845/000119312524239641/d889944dsc13da.htm

Filed Oct 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-239641. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.